EE9400312A - Isosteerilised herpesevastased peptiididerivaadid - Google Patents

Isosteerilised herpesevastased peptiididerivaadid

Info

Publication number
EE9400312A
EE9400312A EE9400312A EE9400312A EE9400312A EE 9400312 A EE9400312 A EE 9400312A EE 9400312 A EE9400312 A EE 9400312A EE 9400312 A EE9400312 A EE 9400312A EE 9400312 A EE9400312 A EE 9400312A
Authority
EE
Estonia
Prior art keywords
alkyl
amino acid
peptide derivatives
isosteric
nhch
Prior art date
Application number
EE9400312A
Other languages
English (en)
Estonian (et)
Inventor
Louis Beaulieu Pierre
D�ziel Robert
Moss Neil
Plante Raymond
Original Assignee
Bio-M�ga/Boehringer Ingelheim Research Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio-M�ga/Boehringer Ingelheim Research Inc. filed Critical Bio-M�ga/Boehringer Ingelheim Research Inc.
Publication of EE9400312A publication Critical patent/EE9400312A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06104Dipeptides with the first amino acid being acidic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EE9400312A 1992-03-12 1994-11-23 Isosteerilised herpesevastased peptiididerivaadid EE9400312A (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84991892A 1992-03-12 1992-03-12

Publications (1)

Publication Number Publication Date
EE9400312A true EE9400312A (et) 1996-04-15

Family

ID=25306833

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400312A EE9400312A (et) 1992-03-12 1994-11-23 Isosteerilised herpesevastased peptiididerivaadid

Country Status (24)

Country Link
EP (1) EP0560267B1 (sk)
JP (1) JPH0625131A (sk)
KR (1) KR950700322A (sk)
AT (1) ATE169931T1 (sk)
BR (1) BR9306074A (sk)
CA (1) CA2131186C (sk)
CZ (1) CZ220994A3 (sk)
DE (1) DE69320390T2 (sk)
EE (1) EE9400312A (sk)
FI (1) FI944187A (sk)
HU (2) HUT68675A (sk)
IL (1) IL105001A0 (sk)
LT (1) LT3270B (sk)
LV (1) LV10461B (sk)
MX (1) MX9301343A (sk)
NO (1) NO943345L (sk)
NZ (1) NZ251266A (sk)
PH (1) PH30453A (sk)
RU (1) RU94040865A (sk)
SG (1) SG42995A1 (sk)
SK (1) SK107794A3 (sk)
TW (1) TW278080B (sk)
WO (1) WO1993018056A1 (sk)
ZA (1) ZA931745B (sk)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5846941A (en) * 1992-03-12 1998-12-08 Boehringer Ingelheim (Canada) Ltd. Isosteric antiherpes peptide derivatives II
CA2095408A1 (en) * 1993-05-03 1994-11-04 James Gus Chafouleas Method of combating acyclovir-resistant herpes simplex viral infections
CA2230750C (en) * 1994-12-28 2002-05-21 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Antiherpes peptidomimetic compounds
CA2152541C (en) * 1995-06-23 1998-12-15 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Herpes ribonucleotide reductase inhibitors
US5948935A (en) * 1997-01-23 1999-09-07 Boehringer Ingelheim (Canada) Ltd. Process and intermediates for (s)-α-amino-1-carboxycyclopentaneacetic acid
EP1053243B1 (en) * 1998-02-12 2011-03-30 Emory University Sphingolipid derivatives and their methods of use
JP5647972B2 (ja) * 2008-04-08 2015-01-07 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung 環状ペプチドを含む組成物および使用方法
WO2020053654A1 (en) 2018-09-12 2020-03-19 Novartis Ag Antiviral pyridopyrazinedione compounds
AU2020353055B2 (en) 2019-09-26 2024-03-07 Gilead Sciences, Inc. Antiviral pyrazolopyridinone compounds

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US481432A (en) 1892-08-23 soler
US4795740A (en) 1986-05-20 1989-01-03 Cohen Eric A Antiviral peptides and means for treating herpes infections
US4845195A (en) 1987-05-22 1989-07-04 Merck & Co., Inc. Inhibitor of ribonucleotide reductase
US4837304A (en) 1987-05-22 1989-06-06 Merck & Co., Inc. Inhibitor of ribonucleotide reductase
ATE123294T1 (de) * 1989-07-07 1995-06-15 Bio Mega Boehringer Ingelheim Antiherpes-tetrapeptid-derivate mit einer substituierten seitenkette aus asparaginsäure.
EP0411334B1 (en) 1989-07-07 1995-02-22 Bio-Mega/Boehringer Ingelheim Research Inc. Antiherpes pentapeptide derivatives having a substituted aspartic acid side chain
CA1340682C (en) * 1989-07-07 1999-07-27 Pierre Lavallee Antiviral peptides having a 2-oxoalkyl amino acid side chain
CA1340684C (en) 1989-07-07 1999-07-27 Pierre Louis Beaulieu Antiherpes pentapeptides
US5110799A (en) 1989-07-28 1992-05-05 Merck & Co., Inc. Antiherpetic agents
CA2018801C (en) 1990-06-12 2000-08-22 Pierre Louis Beaulieu Antiherpes peptide derivatives having a 1,4-dioxo c n-terminus
CA2033447C (en) * 1990-12-31 1999-08-31 Robert Deziel Synergistic combination for treating herpes infections

Also Published As

Publication number Publication date
EP0560267B1 (en) 1998-08-19
NO943345D0 (no) 1994-09-09
NZ251266A (en) 1996-08-27
BR9306074A (pt) 1997-11-18
LV10461A (lv) 1995-02-20
JPH0625131A (ja) 1994-02-01
KR950700322A (ko) 1995-01-16
CA2131186C (en) 2000-12-12
IL105001A0 (en) 1993-07-08
AU3880793A (en) 1993-10-05
HU9402593D0 (en) 1994-11-28
ZA931745B (en) 1993-09-24
DE69320390D1 (de) 1998-09-24
MX9301343A (es) 1994-01-31
FI944187A0 (fi) 1994-09-12
PH30453A (en) 1997-05-28
TW278080B (sk) 1996-06-11
RU94040865A (ru) 1996-08-10
FI944187A (fi) 1994-09-12
WO1993018056A1 (en) 1993-09-16
SK107794A3 (en) 1995-03-08
HU211926A9 (en) 1996-01-29
EP0560267A1 (en) 1993-09-15
ATE169931T1 (de) 1998-09-15
CZ220994A3 (en) 1995-09-13
SG42995A1 (en) 1997-10-17
LT3270B (en) 1995-05-25
AU671825B2 (en) 1996-09-12
NO943345L (no) 1994-09-09
DE69320390T2 (de) 1999-02-11
LTIP408A (en) 1994-09-25
CA2131186A1 (en) 1993-09-16
HUT68675A (en) 1995-07-28
LV10461B (en) 1996-02-20

Similar Documents

Publication Publication Date Title
EE9400312A (et) Isosteerilised herpesevastased peptiididerivaadid
DE69023977T2 (de) Antivirale Peptide, die eine 2-Ketoalkylaminosäureseitenkette enthalten.
ES2152269T3 (es) Inhibidores de ribonucleotido-reductasa de herpesvirus.
ATE167682T1 (de) Peptidderivate mit einem ureido-n-terminus gegen herpes
DE69017113T2 (de) Pentapeptidderivate, wirksam gegen Herpes, die eine ersetzte Asparaginsäureseitenkette enthalten.
CA2019005A1 (en) Antiherpes pentapeptide derivatives having a cycloalkyl substituted aspartic acid side chain